Yaping Sun
Inventor
Stats
- 12 US patents issued
- 31 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 12 US Patents Issued
- 31 US Applications Filed
- 330 Total Citation Count
- Jul 13, 2022 Most Recent Filing
- Oct 11, 2001 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
INCYTE HOLDINGS CORPORATION | 1
2 1 1 | 2013
2014 2016 2017 |
HUAWEI TECHNOLOGIES CO., LTD. | 6
| 2014
|
INCYTE CORPORATION | 5
2 4 | 2015
2016 2017 |
BIOGEN MA INC. | 2
2 2 2 1 | 2004
2010 2011 2012 2014 |
EMD LEXIGEN RESEARCH CENTER CORP. | 1
1 | 2001
2004 |
Inventor Addresses
Address | Duration |
---|---|
Ann Arbor, MI, US | Jul 04, 19 - Nov 03, 22 |
Arlington, MA | Jun 27, 02 - Jun 27, 02 |
Hangzhou, CN | Nov 27, 14 - Dec 27, 16 |
Hockessin, DE, US | Dec 19, 13 - May 23, 19 |
Lansdale, PA, US | Nov 17, 16 - Dec 23, 21 |
Lexington, MA | Oct 19, 06 - Oct 19, 06 |
Lexington, MA, US | Apr 20, 10 - Jan 22, 15 |
New Haven, CT, US | Jul 04, 24 - Jul 04, 24 |
Norwood, MA | Feb 24, 05 - Feb 24, 05 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 13 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 8 |
C07D: | HETEROCYCLIC COMPOUNDS | 18 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2024/0218,055 | 2024 | LASSA VIRUS-SPECIFIC NANOBODIES AND METHODS OF THEIR USE | 0 |
2022/0348,870 | 2022 | MATERIALS AND METHODS FOR MODIFYING THE ACTIVITY OF T CELLS | 0 |
11390848 | 2022 | Materials and methods for modifying the activity of T cells | 0 |
2021/0395,246 | 2021 | BICYCLIC HETEROCYCLES AS FGFR INHIBITORS | 15 |
10947230 | 2021 | Bicyclic heterocycles as FGFR inhibitors | 20 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.